Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging

Launched by UNITED LABORATORIES · Mar 4, 2018

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Healthy individuals age 30 to 60 years old
• • Fitzpatrick Skin Type I-IV
• • Crow's Feet Wrinkle Scale Class 1-2
• • Subjects willing to provide written informed consent
• Exclusion Criteria:
• • Use of topical or oral anti-aging drug therapy 1 month prior to the study
• • History of allergy to cosmetics and anti-aging drugs
• • History of photosensitivity reactions
• • Any current or past medical condition, including seizures and stroke
• • History of pigmentation disorder such as but not limited to vitiligo and leukoderma
• • Immunocompromised state
• • Pregnant or lactating (pregnancy kit will be used to check)
• • Patients who have undergone laser, radiofrequency, peeling, and other procedural therapies for anti-aging in the month prior to the study.
• • Patients with current inflammatory or infectious skin disease on the face, or history of such in the month prior to the study.
• • Patients taking OCDs and other photosensitizing drugs (e.g. tetracycline).
• • Not willing to provide informed consent